Global Peptide Therapeutics Market Growth (Status and Outlook) 2026-2032
The global Peptide Therapeutics market size is predicted to grow from US$ 43350 million in 2025 to US$ 80060 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032.
Peptide therapeutics are a class of pharmaceutical drugs composed of short chains of amino acids, typically ranging from 2 to 50 residues, that mimic natural peptides in the body. These drugs are designed to interact with specific cellular targets, such as receptors, enzymes, or ion channels, to regulate physiological functions. Due to their high specificity, low toxicity, and favorable safety profiles, peptide drugs are widely used in the treatment of various diseases, including cancer, diabetes, cardiovascular diseases, and infectious conditions. With advances in peptide engineering, formulation, and delivery technologies, peptide therapeutics have become a growing segment of the biopharmaceutical industry.The average gross profit margin of this product is 70%.
The Peptide Therapeutics market is driven by the increasing demand for highly specific and efficient treatments for a wide range of diseases, including cancer, diabetes, cardiovascular conditions, and rare genetic disorders. Peptides, due to their high selectivity, low immunogenicity, and close resemblance to natural biological molecules, are well-suited for targeted therapy with fewer side effects. Technological advancements in peptide synthesis, modification, and drug delivery systems have enhanced their stability and extended their half-life, making them more viable for clinical use. Additionally, the growing investment in biopharmaceutical research and development, along with a favorable regulatory environment for innovative therapies, is accelerating the development and approval of peptide-based drugs.
Despite these advantages, the Peptide Therapeutics market faces several challenges, particularly related to drug delivery and manufacturing. Peptides are generally unstable in the gastrointestinal tract and are rapidly degraded by enzymes, limiting their oral bioavailability and often requiring parenteral administration. This can affect patient compliance and limit market penetration. Moreover, the complex and costly manufacturing processes for peptide drugs, including synthesis, purification, and formulation, pose economic and technical barriers, especially for smaller biotech firms. Overcoming these limitations through innovative formulation strategies and cost-efficient production methods is critical for ensuring broader clinical adoption and long-term market growth.
LPI (LP Information)' newest research report, the “Peptide Therapeutics Industry Forecast” looks at past sales and reviews total world Peptide Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Peptide Therapeutics sales for 2026 through 2032. With Peptide Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Peptide Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Peptide therapeutics are a class of pharmaceutical drugs composed of short chains of amino acids, typically ranging from 2 to 50 residues, that mimic natural peptides in the body. These drugs are designed to interact with specific cellular targets, such as receptors, enzymes, or ion channels, to regulate physiological functions. Due to their high specificity, low toxicity, and favorable safety profiles, peptide drugs are widely used in the treatment of various diseases, including cancer, diabetes, cardiovascular diseases, and infectious conditions. With advances in peptide engineering, formulation, and delivery technologies, peptide therapeutics have become a growing segment of the biopharmaceutical industry.The average gross profit margin of this product is 70%.
The Peptide Therapeutics market is driven by the increasing demand for highly specific and efficient treatments for a wide range of diseases, including cancer, diabetes, cardiovascular conditions, and rare genetic disorders. Peptides, due to their high selectivity, low immunogenicity, and close resemblance to natural biological molecules, are well-suited for targeted therapy with fewer side effects. Technological advancements in peptide synthesis, modification, and drug delivery systems have enhanced their stability and extended their half-life, making them more viable for clinical use. Additionally, the growing investment in biopharmaceutical research and development, along with a favorable regulatory environment for innovative therapies, is accelerating the development and approval of peptide-based drugs.
Despite these advantages, the Peptide Therapeutics market faces several challenges, particularly related to drug delivery and manufacturing. Peptides are generally unstable in the gastrointestinal tract and are rapidly degraded by enzymes, limiting their oral bioavailability and often requiring parenteral administration. This can affect patient compliance and limit market penetration. Moreover, the complex and costly manufacturing processes for peptide drugs, including synthesis, purification, and formulation, pose economic and technical barriers, especially for smaller biotech firms. Overcoming these limitations through innovative formulation strategies and cost-efficient production methods is critical for ensuring broader clinical adoption and long-term market growth.
LPI (LP Information)' newest research report, the “Peptide Therapeutics Industry Forecast” looks at past sales and reviews total world Peptide Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Peptide Therapeutics sales for 2026 through 2032. With Peptide Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Peptide Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Injection
- Oral
- Other
- Agonist/Analog
- Antagonist
- Enzyme Inhibitor
- Ion Channel
- Retail
- Hospital
- Other
- Cancer
- Metabolic Disorders
- Central Nervous System
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Teva
- Novo Nordisk
- Takeda
- Eli Lilly
- AstraZeneca
- Novartis
- AbbVie
- Ipsen
- Ferring
- Merck
- The Medicines
- J & J
- Aurinia Pharmaceuticals
- BioMarin Pharmaceutical
- Apellis Pharmaceuticals
- Lantheus
- CSL Vifor Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Therapeutics Market Size (2021-2032)
2.1.2 Peptide Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Peptide Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Peptide Therapeutics Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.2.4 Peptide Therapeutics Market Size by Type
2.2.4.1 Peptide Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Peptide Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Peptide Therapeutics Segment by Target Class
2.3.1 Agonist/Analog
2.3.2 Antagonist
2.3.3 Enzyme Inhibitor
2.3.4 Ion Channel
2.3.5 Peptide Therapeutics Market Size by Target Class
2.3.5.1 Peptide Therapeutics Market Size CAGR by Target Class (2021 VS 2025 VS 2032)
2.3.5.2 Global Peptide Therapeutics Market Size Market Share by Target Class (2021-2026)
2.4 Peptide Therapeutics Segment by End Users
2.4.1 Retail
2.4.2 Hospital
2.4.3 Other
2.4.4 Peptide Therapeutics Market Size by End Users
2.4.4.1 Peptide Therapeutics Market Size CAGR by End Users (2021 VS 2025 VS 2032)
2.4.4.2 Global Peptide Therapeutics Market Size Market Share by End Users (2021-2026)
2.5 Peptide Therapeutics Segment by Application
2.5.1 Cancer
2.5.2 Metabolic Disorders
2.5.3 Central Nervous System
2.5.4 Other
2.5.5 Peptide Therapeutics Market Size by Application
2.5.5.1 Peptide Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Peptide Therapeutics Market Size Market Share by Application (2021-2026)
3 PEPTIDE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Peptide Therapeutics Market Size Market Share by Player
3.1.1 Global Peptide Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Peptide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE THERAPEUTICS BY REGION
4.1 Peptide Therapeutics Market Size by Region (2021-2026)
4.2 Global Peptide Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peptide Therapeutics Market Size Growth (2021-2026)
4.4 APAC Peptide Therapeutics Market Size Growth (2021-2026)
4.5 Europe Peptide Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Peptide Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Peptide Therapeutics Market Size by Country (2021-2026)
5.2 Americas Peptide Therapeutics Market Size by Type (2021-2026)
5.3 Americas Peptide Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Therapeutics Market Size by Region (2021-2026)
6.2 APAC Peptide Therapeutics Market Size by Type (2021-2026)
6.3 APAC Peptide Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide Therapeutics Market Size by Country (2021-2026)
7.2 Europe Peptide Therapeutics Market Size by Type (2021-2026)
7.3 Europe Peptide Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Peptide Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Peptide Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE THERAPEUTICS MARKET FORECAST
10.1 Global Peptide Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Peptide Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Peptide Therapeutics Forecast
10.1.3 APAC Peptide Therapeutics Forecast
10.1.4 Europe Peptide Therapeutics Forecast
10.1.5 Middle East & Africa Peptide Therapeutics Forecast
10.2 Americas Peptide Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Peptide Therapeutics Forecast
10.2.2 Canada Market Peptide Therapeutics Forecast
10.2.3 Mexico Market Peptide Therapeutics Forecast
10.2.4 Brazil Market Peptide Therapeutics Forecast
10.3 APAC Peptide Therapeutics Forecast by Region (2027-2032)
10.3.1 China Peptide Therapeutics Market Forecast
10.3.2 Japan Market Peptide Therapeutics Forecast
10.3.3 Korea Market Peptide Therapeutics Forecast
10.3.4 Southeast Asia Market Peptide Therapeutics Forecast
10.3.5 India Market Peptide Therapeutics Forecast
10.3.6 Australia Market Peptide Therapeutics Forecast
10.4 Europe Peptide Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Peptide Therapeutics Forecast
10.4.2 France Market Peptide Therapeutics Forecast
10.4.3 UK Market Peptide Therapeutics Forecast
10.4.4 Italy Market Peptide Therapeutics Forecast
10.4.5 Russia Market Peptide Therapeutics Forecast
10.5 Middle East & Africa Peptide Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Peptide Therapeutics Forecast
10.5.2 South Africa Market Peptide Therapeutics Forecast
10.5.3 Israel Market Peptide Therapeutics Forecast
10.5.4 Turkey Market Peptide Therapeutics Forecast
10.6 Global Peptide Therapeutics Forecast by Type (2027-2032)
10.7 Global Peptide Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Peptide Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide Therapeutics Product Offered
11.1.3 Sanofi Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide Therapeutics Product Offered
11.2.3 Teva Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide Therapeutics Product Offered
11.3.3 Novo Nordisk Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide Therapeutics Product Offered
11.4.3 Takeda Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide Therapeutics Product Offered
11.5.3 Eli Lilly Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide Therapeutics Product Offered
11.6.3 AstraZeneca Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide Therapeutics Product Offered
11.7.3 Novartis Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide Therapeutics Product Offered
11.8.3 AbbVie Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide Therapeutics Product Offered
11.9.3 Ipsen Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide Therapeutics Product Offered
11.10.3 Ferring Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide Therapeutics Product Offered
11.11.3 Merck Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide Therapeutics Product Offered
11.12.3 The Medicines Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide Therapeutics Product Offered
11.13.3 J & J Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
11.14 Aurinia Pharmaceuticals
11.14.1 Aurinia Pharmaceuticals Company Information
11.14.2 Aurinia Pharmaceuticals Peptide Therapeutics Product Offered
11.14.3 Aurinia Pharmaceuticals Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Aurinia Pharmaceuticals Main Business Overview
11.14.5 Aurinia Pharmaceuticals Latest Developments
11.15 BioMarin Pharmaceutical
11.15.1 BioMarin Pharmaceutical Company Information
11.15.2 BioMarin Pharmaceutical Peptide Therapeutics Product Offered
11.15.3 BioMarin Pharmaceutical Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 BioMarin Pharmaceutical Main Business Overview
11.15.5 BioMarin Pharmaceutical Latest Developments
11.16 Apellis Pharmaceuticals
11.16.1 Apellis Pharmaceuticals Company Information
11.16.2 Apellis Pharmaceuticals Peptide Therapeutics Product Offered
11.16.3 Apellis Pharmaceuticals Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Apellis Pharmaceuticals Main Business Overview
11.16.5 Apellis Pharmaceuticals Latest Developments
11.17 Lantheus
11.17.1 Lantheus Company Information
11.17.2 Lantheus Peptide Therapeutics Product Offered
11.17.3 Lantheus Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Lantheus Main Business Overview
11.17.5 Lantheus Latest Developments
11.18 CSL Vifor Group
11.18.1 CSL Vifor Group Company Information
11.18.2 CSL Vifor Group Peptide Therapeutics Product Offered
11.18.3 CSL Vifor Group Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 CSL Vifor Group Main Business Overview
11.18.5 CSL Vifor Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Therapeutics Market Size (2021-2032)
2.1.2 Peptide Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Peptide Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Peptide Therapeutics Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 Other
2.2.4 Peptide Therapeutics Market Size by Type
2.2.4.1 Peptide Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Peptide Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Peptide Therapeutics Segment by Target Class
2.3.1 Agonist/Analog
2.3.2 Antagonist
2.3.3 Enzyme Inhibitor
2.3.4 Ion Channel
2.3.5 Peptide Therapeutics Market Size by Target Class
2.3.5.1 Peptide Therapeutics Market Size CAGR by Target Class (2021 VS 2025 VS 2032)
2.3.5.2 Global Peptide Therapeutics Market Size Market Share by Target Class (2021-2026)
2.4 Peptide Therapeutics Segment by End Users
2.4.1 Retail
2.4.2 Hospital
2.4.3 Other
2.4.4 Peptide Therapeutics Market Size by End Users
2.4.4.1 Peptide Therapeutics Market Size CAGR by End Users (2021 VS 2025 VS 2032)
2.4.4.2 Global Peptide Therapeutics Market Size Market Share by End Users (2021-2026)
2.5 Peptide Therapeutics Segment by Application
2.5.1 Cancer
2.5.2 Metabolic Disorders
2.5.3 Central Nervous System
2.5.4 Other
2.5.5 Peptide Therapeutics Market Size by Application
2.5.5.1 Peptide Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Peptide Therapeutics Market Size Market Share by Application (2021-2026)
3 PEPTIDE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Peptide Therapeutics Market Size Market Share by Player
3.1.1 Global Peptide Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Peptide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE THERAPEUTICS BY REGION
4.1 Peptide Therapeutics Market Size by Region (2021-2026)
4.2 Global Peptide Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Peptide Therapeutics Market Size Growth (2021-2026)
4.4 APAC Peptide Therapeutics Market Size Growth (2021-2026)
4.5 Europe Peptide Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Peptide Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Peptide Therapeutics Market Size by Country (2021-2026)
5.2 Americas Peptide Therapeutics Market Size by Type (2021-2026)
5.3 Americas Peptide Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Therapeutics Market Size by Region (2021-2026)
6.2 APAC Peptide Therapeutics Market Size by Type (2021-2026)
6.3 APAC Peptide Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide Therapeutics Market Size by Country (2021-2026)
7.2 Europe Peptide Therapeutics Market Size by Type (2021-2026)
7.3 Europe Peptide Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Peptide Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Peptide Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE THERAPEUTICS MARKET FORECAST
10.1 Global Peptide Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Peptide Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Peptide Therapeutics Forecast
10.1.3 APAC Peptide Therapeutics Forecast
10.1.4 Europe Peptide Therapeutics Forecast
10.1.5 Middle East & Africa Peptide Therapeutics Forecast
10.2 Americas Peptide Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Peptide Therapeutics Forecast
10.2.2 Canada Market Peptide Therapeutics Forecast
10.2.3 Mexico Market Peptide Therapeutics Forecast
10.2.4 Brazil Market Peptide Therapeutics Forecast
10.3 APAC Peptide Therapeutics Forecast by Region (2027-2032)
10.3.1 China Peptide Therapeutics Market Forecast
10.3.2 Japan Market Peptide Therapeutics Forecast
10.3.3 Korea Market Peptide Therapeutics Forecast
10.3.4 Southeast Asia Market Peptide Therapeutics Forecast
10.3.5 India Market Peptide Therapeutics Forecast
10.3.6 Australia Market Peptide Therapeutics Forecast
10.4 Europe Peptide Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Peptide Therapeutics Forecast
10.4.2 France Market Peptide Therapeutics Forecast
10.4.3 UK Market Peptide Therapeutics Forecast
10.4.4 Italy Market Peptide Therapeutics Forecast
10.4.5 Russia Market Peptide Therapeutics Forecast
10.5 Middle East & Africa Peptide Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Peptide Therapeutics Forecast
10.5.2 South Africa Market Peptide Therapeutics Forecast
10.5.3 Israel Market Peptide Therapeutics Forecast
10.5.4 Turkey Market Peptide Therapeutics Forecast
10.6 Global Peptide Therapeutics Forecast by Type (2027-2032)
10.7 Global Peptide Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Peptide Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Peptide Therapeutics Product Offered
11.1.3 Sanofi Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Peptide Therapeutics Product Offered
11.2.3 Teva Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Peptide Therapeutics Product Offered
11.3.3 Novo Nordisk Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Peptide Therapeutics Product Offered
11.4.3 Takeda Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Peptide Therapeutics Product Offered
11.5.3 Eli Lilly Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Peptide Therapeutics Product Offered
11.6.3 AstraZeneca Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Peptide Therapeutics Product Offered
11.7.3 Novartis Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Peptide Therapeutics Product Offered
11.8.3 AbbVie Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Peptide Therapeutics Product Offered
11.9.3 Ipsen Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Peptide Therapeutics Product Offered
11.10.3 Ferring Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Peptide Therapeutics Product Offered
11.11.3 Merck Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Peptide Therapeutics Product Offered
11.12.3 The Medicines Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Peptide Therapeutics Product Offered
11.13.3 J & J Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
11.14 Aurinia Pharmaceuticals
11.14.1 Aurinia Pharmaceuticals Company Information
11.14.2 Aurinia Pharmaceuticals Peptide Therapeutics Product Offered
11.14.3 Aurinia Pharmaceuticals Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Aurinia Pharmaceuticals Main Business Overview
11.14.5 Aurinia Pharmaceuticals Latest Developments
11.15 BioMarin Pharmaceutical
11.15.1 BioMarin Pharmaceutical Company Information
11.15.2 BioMarin Pharmaceutical Peptide Therapeutics Product Offered
11.15.3 BioMarin Pharmaceutical Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 BioMarin Pharmaceutical Main Business Overview
11.15.5 BioMarin Pharmaceutical Latest Developments
11.16 Apellis Pharmaceuticals
11.16.1 Apellis Pharmaceuticals Company Information
11.16.2 Apellis Pharmaceuticals Peptide Therapeutics Product Offered
11.16.3 Apellis Pharmaceuticals Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Apellis Pharmaceuticals Main Business Overview
11.16.5 Apellis Pharmaceuticals Latest Developments
11.17 Lantheus
11.17.1 Lantheus Company Information
11.17.2 Lantheus Peptide Therapeutics Product Offered
11.17.3 Lantheus Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Lantheus Main Business Overview
11.17.5 Lantheus Latest Developments
11.18 CSL Vifor Group
11.18.1 CSL Vifor Group Company Information
11.18.2 CSL Vifor Group Peptide Therapeutics Product Offered
11.18.3 CSL Vifor Group Peptide Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 CSL Vifor Group Main Business Overview
11.18.5 CSL Vifor Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Peptide Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Major Players of Other
Table 6. Peptide Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Agonist/Analog
Table 10. Major Players of Antagonist
Table 11. Major Players of Enzyme Inhibitor
Table 12. Major Players of Ion Channel
Table 13. Peptide Therapeutics Market Size CAGR by Target Class (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Peptide Therapeutics Market Size by Target Class (2021-2026) & ($ millions)
Table 15. Global Peptide Therapeutics Market Size Market Share by Target Class (2021-2026)
Table 16. Major Players of Retail
Table 17. Major Players of Hospital
Table 18. Major Players of Other
Table 19. Peptide Therapeutics Market Size CAGR by End Users (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Peptide Therapeutics Market Size by End Users (2021-2026) & ($ millions)
Table 21. Global Peptide Therapeutics Market Size Market Share by End Users (2021-2026)
Table 22. Peptide Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Table 25. Global Peptide Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Peptide Therapeutics Revenue Market Share by Player (2021-2026)
Table 27. Peptide Therapeutics Key Players Head office and Products Offered
Table 28. Peptide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Peptide Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Table 33. Global Peptide Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Peptide Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Peptide Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Peptide Therapeutics Market Size Market Share by Country (2021-2026)
Table 37. Americas Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Table 39. Americas Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Table 41. APAC Peptide Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Table 43. APAC Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Peptide Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Peptide Therapeutics Market Size Market Share by Country (2021-2026)
Table 47. Europe Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Peptide Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Peptide Therapeutics
Table 53. Key Market Challenges & Risks of Peptide Therapeutics
Table 54. Key Industry Trends of Peptide Therapeutics
Table 55. Global Peptide Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Peptide Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Peptide Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Peptide Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Sanofi Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 60. Sanofi Peptide Therapeutics Product Offered
Table 61. Sanofi Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Sanofi Main Business
Table 63. Sanofi Latest Developments
Table 64. Teva Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 65. Teva Peptide Therapeutics Product Offered
Table 66. Teva Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Teva Main Business
Table 68. Teva Latest Developments
Table 69. Novo Nordisk Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 70. Novo Nordisk Peptide Therapeutics Product Offered
Table 71. Novo Nordisk Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Novo Nordisk Main Business
Table 73. Novo Nordisk Latest Developments
Table 74. Takeda Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 75. Takeda Peptide Therapeutics Product Offered
Table 76. Takeda Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Takeda Main Business
Table 78. Takeda Latest Developments
Table 79. Eli Lilly Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 80. Eli Lilly Peptide Therapeutics Product Offered
Table 81. Eli Lilly Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Eli Lilly Main Business
Table 83. Eli Lilly Latest Developments
Table 84. AstraZeneca Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 85. AstraZeneca Peptide Therapeutics Product Offered
Table 86. AstraZeneca Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Novartis Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 90. Novartis Peptide Therapeutics Product Offered
Table 91. Novartis Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. AbbVie Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 95. AbbVie Peptide Therapeutics Product Offered
Table 96. AbbVie Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. AbbVie Main Business
Table 98. AbbVie Latest Developments
Table 99. Ipsen Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 100. Ipsen Peptide Therapeutics Product Offered
Table 101. Ipsen Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Ipsen Main Business
Table 103. Ipsen Latest Developments
Table 104. Ferring Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 105. Ferring Peptide Therapeutics Product Offered
Table 106. Ferring Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Ferring Main Business
Table 108. Ferring Latest Developments
Table 109. Merck Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 110. Merck Peptide Therapeutics Product Offered
Table 111. Merck Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. The Medicines Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 115. The Medicines Peptide Therapeutics Product Offered
Table 116. The Medicines Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. The Medicines Main Business
Table 118. The Medicines Latest Developments
Table 119. J & J Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 120. J & J Peptide Therapeutics Product Offered
Table 121. J & J Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. J & J Main Business
Table 123. J & J Latest Developments
Table 124. Aurinia Pharmaceuticals Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 125. Aurinia Pharmaceuticals Peptide Therapeutics Product Offered
Table 126. Aurinia Pharmaceuticals Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Aurinia Pharmaceuticals Main Business
Table 128. Aurinia Pharmaceuticals Latest Developments
Table 129. BioMarin Pharmaceutical Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 130. BioMarin Pharmaceutical Peptide Therapeutics Product Offered
Table 131. BioMarin Pharmaceutical Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. BioMarin Pharmaceutical Main Business
Table 133. BioMarin Pharmaceutical Latest Developments
Table 134. Apellis Pharmaceuticals Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 135. Apellis Pharmaceuticals Peptide Therapeutics Product Offered
Table 136. Apellis Pharmaceuticals Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Apellis Pharmaceuticals Main Business
Table 138. Apellis Pharmaceuticals Latest Developments
Table 139. Lantheus Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 140. Lantheus Peptide Therapeutics Product Offered
Table 141. Lantheus Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Lantheus Main Business
Table 143. Lantheus Latest Developments
Table 144. CSL Vifor Group Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 145. CSL Vifor Group Peptide Therapeutics Product Offered
Table 146. CSL Vifor Group Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. CSL Vifor Group Main Business
Table 148. CSL Vifor Group Latest Developments
Table 1. Peptide Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Peptide Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Major Players of Other
Table 6. Peptide Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Agonist/Analog
Table 10. Major Players of Antagonist
Table 11. Major Players of Enzyme Inhibitor
Table 12. Major Players of Ion Channel
Table 13. Peptide Therapeutics Market Size CAGR by Target Class (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Peptide Therapeutics Market Size by Target Class (2021-2026) & ($ millions)
Table 15. Global Peptide Therapeutics Market Size Market Share by Target Class (2021-2026)
Table 16. Major Players of Retail
Table 17. Major Players of Hospital
Table 18. Major Players of Other
Table 19. Peptide Therapeutics Market Size CAGR by End Users (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Peptide Therapeutics Market Size by End Users (2021-2026) & ($ millions)
Table 21. Global Peptide Therapeutics Market Size Market Share by End Users (2021-2026)
Table 22. Peptide Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Table 25. Global Peptide Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Peptide Therapeutics Revenue Market Share by Player (2021-2026)
Table 27. Peptide Therapeutics Key Players Head office and Products Offered
Table 28. Peptide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Peptide Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Table 33. Global Peptide Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Peptide Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Peptide Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Peptide Therapeutics Market Size Market Share by Country (2021-2026)
Table 37. Americas Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Table 39. Americas Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Table 41. APAC Peptide Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Table 43. APAC Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Peptide Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Peptide Therapeutics Market Size Market Share by Country (2021-2026)
Table 47. Europe Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Peptide Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Peptide Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Peptide Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Peptide Therapeutics
Table 53. Key Market Challenges & Risks of Peptide Therapeutics
Table 54. Key Industry Trends of Peptide Therapeutics
Table 55. Global Peptide Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Peptide Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Peptide Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Peptide Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Sanofi Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 60. Sanofi Peptide Therapeutics Product Offered
Table 61. Sanofi Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Sanofi Main Business
Table 63. Sanofi Latest Developments
Table 64. Teva Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 65. Teva Peptide Therapeutics Product Offered
Table 66. Teva Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Teva Main Business
Table 68. Teva Latest Developments
Table 69. Novo Nordisk Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 70. Novo Nordisk Peptide Therapeutics Product Offered
Table 71. Novo Nordisk Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Novo Nordisk Main Business
Table 73. Novo Nordisk Latest Developments
Table 74. Takeda Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 75. Takeda Peptide Therapeutics Product Offered
Table 76. Takeda Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Takeda Main Business
Table 78. Takeda Latest Developments
Table 79. Eli Lilly Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 80. Eli Lilly Peptide Therapeutics Product Offered
Table 81. Eli Lilly Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Eli Lilly Main Business
Table 83. Eli Lilly Latest Developments
Table 84. AstraZeneca Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 85. AstraZeneca Peptide Therapeutics Product Offered
Table 86. AstraZeneca Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Novartis Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 90. Novartis Peptide Therapeutics Product Offered
Table 91. Novartis Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Novartis Main Business
Table 93. Novartis Latest Developments
Table 94. AbbVie Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 95. AbbVie Peptide Therapeutics Product Offered
Table 96. AbbVie Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. AbbVie Main Business
Table 98. AbbVie Latest Developments
Table 99. Ipsen Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 100. Ipsen Peptide Therapeutics Product Offered
Table 101. Ipsen Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Ipsen Main Business
Table 103. Ipsen Latest Developments
Table 104. Ferring Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 105. Ferring Peptide Therapeutics Product Offered
Table 106. Ferring Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Ferring Main Business
Table 108. Ferring Latest Developments
Table 109. Merck Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 110. Merck Peptide Therapeutics Product Offered
Table 111. Merck Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. The Medicines Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 115. The Medicines Peptide Therapeutics Product Offered
Table 116. The Medicines Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. The Medicines Main Business
Table 118. The Medicines Latest Developments
Table 119. J & J Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 120. J & J Peptide Therapeutics Product Offered
Table 121. J & J Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. J & J Main Business
Table 123. J & J Latest Developments
Table 124. Aurinia Pharmaceuticals Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 125. Aurinia Pharmaceuticals Peptide Therapeutics Product Offered
Table 126. Aurinia Pharmaceuticals Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Aurinia Pharmaceuticals Main Business
Table 128. Aurinia Pharmaceuticals Latest Developments
Table 129. BioMarin Pharmaceutical Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 130. BioMarin Pharmaceutical Peptide Therapeutics Product Offered
Table 131. BioMarin Pharmaceutical Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. BioMarin Pharmaceutical Main Business
Table 133. BioMarin Pharmaceutical Latest Developments
Table 134. Apellis Pharmaceuticals Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 135. Apellis Pharmaceuticals Peptide Therapeutics Product Offered
Table 136. Apellis Pharmaceuticals Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Apellis Pharmaceuticals Main Business
Table 138. Apellis Pharmaceuticals Latest Developments
Table 139. Lantheus Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 140. Lantheus Peptide Therapeutics Product Offered
Table 141. Lantheus Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Lantheus Main Business
Table 143. Lantheus Latest Developments
Table 144. CSL Vifor Group Details, Company Type, Peptide Therapeutics Area Served and Its Competitors
Table 145. CSL Vifor Group Peptide Therapeutics Product Offered
Table 146. CSL Vifor Group Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. CSL Vifor Group Main Business
Table 148. CSL Vifor Group Latest Developments
LIST OF FIGURES
Figure 1. Peptide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Peptide Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Peptide Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Peptide Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Peptide Therapeutics Market Size Market Share by Type in 2025
Figure 10. Global Peptide Therapeutics Market Size Market Share by Target Class in 2025
Figure 11. Global Peptide Therapeutics Market Size Market Share by End Users in 2025
Figure 12. Peptide Therapeutics in Cancer
Figure 13. Global Peptide Therapeutics Market: Cancer (2021-2026) & ($ millions)
Figure 14. Peptide Therapeutics in Metabolic Disorders
Figure 15. Global Peptide Therapeutics Market: Metabolic Disorders (2021-2026) & ($ millions)
Figure 16. Peptide Therapeutics in Central Nervous System
Figure 17. Global Peptide Therapeutics Market: Central Nervous System (2021-2026) & ($ millions)
Figure 18. Peptide Therapeutics in Other
Figure 19. Global Peptide Therapeutics Market: Other (2021-2026) & ($ millions)
Figure 20. Global Peptide Therapeutics Market Size Market Share by Application in 2025
Figure 21. Global Peptide Therapeutics Revenue Market Share by Player in 2025
Figure 22. Global Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Figure 23. Americas Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 24. APAC Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 25. Europe Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 27. Americas Peptide Therapeutics Value Market Share by Country in 2025
Figure 28. United States Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Peptide Therapeutics Market Size Market Share by Region in 2025
Figure 33. APAC Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Figure 34. APAC Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Figure 35. China Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 39. India Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Peptide Therapeutics Market Size Market Share by Country in 2025
Figure 42. Europe Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Figure 43. Europe Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Figure 44. Germany Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. France Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. APAC Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Europe Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. United States Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Canada Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Mexico Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Brazil Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. China Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Japan Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Korea Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. India Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Australia Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Germany Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. France Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. UK Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Italy Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Russia Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Egypt Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 77. South Africa Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 78. Israel Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 79. Turkey Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 80. Global Peptide Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Peptide Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 1. Peptide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Peptide Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Peptide Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Peptide Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Peptide Therapeutics Market Size Market Share by Type in 2025
Figure 10. Global Peptide Therapeutics Market Size Market Share by Target Class in 2025
Figure 11. Global Peptide Therapeutics Market Size Market Share by End Users in 2025
Figure 12. Peptide Therapeutics in Cancer
Figure 13. Global Peptide Therapeutics Market: Cancer (2021-2026) & ($ millions)
Figure 14. Peptide Therapeutics in Metabolic Disorders
Figure 15. Global Peptide Therapeutics Market: Metabolic Disorders (2021-2026) & ($ millions)
Figure 16. Peptide Therapeutics in Central Nervous System
Figure 17. Global Peptide Therapeutics Market: Central Nervous System (2021-2026) & ($ millions)
Figure 18. Peptide Therapeutics in Other
Figure 19. Global Peptide Therapeutics Market: Other (2021-2026) & ($ millions)
Figure 20. Global Peptide Therapeutics Market Size Market Share by Application in 2025
Figure 21. Global Peptide Therapeutics Revenue Market Share by Player in 2025
Figure 22. Global Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Figure 23. Americas Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 24. APAC Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 25. Europe Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Peptide Therapeutics Market Size 2021-2026 ($ millions)
Figure 27. Americas Peptide Therapeutics Value Market Share by Country in 2025
Figure 28. United States Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Peptide Therapeutics Market Size Market Share by Region in 2025
Figure 33. APAC Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Figure 34. APAC Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Figure 35. China Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 39. India Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Peptide Therapeutics Market Size Market Share by Country in 2025
Figure 42. Europe Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Figure 43. Europe Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Figure 44. Germany Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. France Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Peptide Therapeutics Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Peptide Therapeutics Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Peptide Therapeutics Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Peptide Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. APAC Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Europe Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. United States Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Canada Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Mexico Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Brazil Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. China Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Japan Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Korea Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. India Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Australia Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Germany Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. France Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. UK Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Italy Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Russia Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Egypt Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 77. South Africa Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 78. Israel Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 79. Turkey Peptide Therapeutics Market Size 2027-2032 ($ millions)
Figure 80. Global Peptide Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Peptide Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Peptide Therapeutics Market Size 2027-2032 ($ millions)
